Skip to content
Primary Endpoint Solutions
Optimizing Clinical Trials
Primary Endpoint SolutionsPrimary Endpoint Solutions
  • Partnering With PES
  • Services
    • Clinical Rater Training
    • Trial Preparation
    • Expert Data Review & Centralized Scoring
    • Ancillary Clinical Supplies
    • Radiation Therapy Quality Assurance
    • Genomics & Biomarkers
  • About PES
    • Primary Endpoint Solutions Team
    • Publications
  • Contact Us
  • Primary Endpoint Solutions
  • Partner
  • About
  • Publications
  • Contact Us

Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction

You are here:
  1. Home
  2. Publications
  3. Cytokine-mediated blood brain barrier disruption…
 Wiley Online Library

Project navigation

PreviousPrevious project:Exploring Genetic Attributions Underlying Radiotherapy-Induced Fatigue in Prostate Cancer PatientsNextNext project:Could the biological robustness of low-level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients
Recent Comments

    clinical trial data accuracy

    Copyright Primary Endpoint Solutions 2020

    Primary Endpoint Solutions

    PES’s integrated services eliminate inconsistent and incomplete trial data, ensuring that the selection, capture, accuracy, and analysis of endpoints is optimized.

    • Primary Endpoint Solutions
    • Partner
    • About
    • Publications
    • Contact Us
    Go to Top